FinancialContent

ZimVie Inc. - Common Stock (NQ:ZIMV)

18.99 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ZimVie Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
ZimVie (ZIMV) Q1 2024 Earnings Call Transcript ↗
ZIMV earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
ZimVie Reports First Quarter 2024 Financial Results
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie to Report First Quarter Financial Results on May 8, 2024
From ZimVie Inc.
Via GlobeNewswire
News headline image
Recap: ZimVie Q4 Earnings ↗
 
Via Benzinga
News headline image
A Preview Of ZimVie's Earnings ↗
 
Via Benzinga
News headline image
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
ZimVie Announces Closing of Sale of Spine Business
Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business 
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie (ZIMV) Q4 2023 Earnings Call Transcript ↗
ZIMV earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
From ZimVie Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For February 28, 2024 ↗
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
News headline image
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
Newest implant innovation is designed for immediacy and peri-implant health 
From ZimVie Inc.
Via GlobeNewswire
News headline image
Fear & Greed Index Moves To 'Extreme Greed' Zone; S&P 500 Settles Higher ↗
The CNN Money Fear and Greed index showed some easing in overall market sentiment, but the index moved to the "Extreme Greed" zone on Monday. The S&P 500 closed higher on Monday after recording gains... 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher ↗
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07.... 
Via Benzinga
Topics Stocks
News headline image
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Rises 3%; US Housing Market Index Increases In December ↗
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
Why Surgical And Medical Instrument Manufacturing Company ZimVie Shares Are Rocketing Today ↗
ZimVie Inc (NASDAQ: ZIMV) shares are trading higher by over 33% after the company disclosed an agreement to sell its spine business to  
Via Benzinga
News headline image
ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie (ZIMV) Q3 2023 Earnings Call Transcript ↗
ZIMV earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
From ZimVie Inc.
Via GlobeNewswire
News headline image
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
From ZimVie Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 1, 2023 ↗
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
News headline image
Brace for Impact: 7 Stocks to Sell Amid Rising Troubles ↗
Although few really enjoy talking about the subject, targeting stocks to sell is just as important for success as acquiring good ideas. 
Via InvestorPlace
News headline image
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
New offerings expand ZimVie’s dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio 
From ZimVie Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >